ABT-639

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameABT-639
Drug Alias NameABT-639
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated T-type calcium channel blockers
TargetsVoltage-gated T-type calcium channel
Therapy Area/IndicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesMexico +[6] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbvie Inc
Active IndicationsN/A
Inactive IndicationsDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A